Stratagene California was an American biotechnological company based in La Jolla, California,[1] a maker of life science research and diagnostic products.
[3] It has been involved with the fields of cellular analysis, cloning, cytogenomics, DNA methylation and DNA Sizing and Quantification[1] and food testing.
In 2007, Agilent Technologies acquired Stratagene for $250 million,[4] spinning off certain business assets and licensing certain molecular diagnostics technology to a new entity, Decisive Diagnostics.
[5][2] As of October 2011, the Chief Executive of the new company is Joseph Sorge, original founder and CEO of Stratagene.
This United States corporation or company article is a stub.